LDR | |
00990cam a2200289 4500 |
001 |
|
011324701 |
003 |
|
MiAaHDL |
005 |
|
20141017000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
790314s1971 mdu b f000 0 eng |
010 |
⊔ |
⊔ |
‡a 73611702
|
035 |
⊔ |
⊔ |
‡asdr-pur2611022
|
035 |
⊔ |
⊔ |
‡a2611022
|
035 |
⊔ |
⊔ |
‡a(OCoLC)5009469
|
040 |
⊔ |
⊔ |
‡aDLC
‡cDLC
‡dOCLCQ
‡dIUL
‡dOCLCG
‡dCLU
|
049 |
⊔ |
⊔ |
‡aIPL1
|
050 |
0 |
4 |
‡aRM322
‡b.R67
|
082 |
⊔ |
⊔ |
‡a615/.784
|
086 |
0 |
⊔ |
‡aHE 20.3502:B 62
|
100 |
1 |
⊔ |
‡aRose, Stephen W.
|
245 |
1 |
0 |
‡aBlood level determinations of antiepileptic drugs;
‡bclinical value and methods
‡c[by] Stephen W. Rose, Lawrence D. Smith, and J. Kiffin Penry.
|
260 |
⊔ |
⊔ |
‡a[Bethesda, Md.,
‡bU.S. National Institutes of Health]
‡c1971.
|
300 |
⊔ |
⊔ |
‡a33, [10] p.
‡c26 cm.
|
504 |
⊔ |
⊔ |
‡aIncludes bibliographical references.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
0 |
‡aBlood
‡xAnalysis.
|
650 |
⊔ |
0 |
‡aAnticonvulsants
‡xAnalysis.
|
700 |
1 |
⊔ |
‡aPenry, J. Kiffin,
‡d1929-
|
700 |
1 |
⊔ |
‡aSmith, Lawrence D.
|
CID |
⊔ |
⊔ |
‡a011324701
|
DAT |
0 |
⊔ |
‡a20101018003655.0
‡b20141017000000.0
|
DAT |
1 |
⊔ |
‡a20141017161408.0
‡b2024-09-29T18:26:44Z
|
DAT |
2 |
⊔ |
‡a2024-09-29T17:30:02Z
|
CAT |
⊔ |
⊔ |
‡aSDR-PUR
‡dUNKNOWN
‡lloader.pl-003-020
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-pur2611022
‡apur1
‡bSDR
‡cPUR
‡ppur1.32754081178661
‡sPUR
‡12611022
|
974 |
⊔ |
⊔ |
‡bPUR
‡cPUR
‡d20240929
‡sgoogle
‡upur1.32754081178661
‡y1971
‡rpd
‡qbib
‡tUS fed doc
|